The peptide library
Every entry states its evidence level and approval status up front. Filter by what the research shows, not by what a product page claims.
CJC-1295
A modified growth-hormone-releasing hormone analogue whose albumin binding gives it an unusually long action. Studied in small human trials; not an approved medicine.
CJC-1295 (no DAC) + Ipamorelin blend
The classic growth-hormone stack in one vial: a GHRH fragment with a secretagogue, unapproved and prohibited in sport.
CJC-1295 (no DAC) / mod GRF 1-29
The short-acting sister of CJC-1295: a GHRH fragment that produces brief growth-hormone pulses instead of sustained elevation.
GHRP-2 (pralmorelin)
A potent ghrelin-receptor secretagogue used in some countries as a growth-hormone test; sold unapproved for body composition.
GHRP-6
A ghrelin-receptor secretagogue that reliably raises growth hormone and hunger; unapproved and prohibited in sport.
Hexarelin
One of the strongest growth-hormone secretagogues in its class, studied mostly for hormone release and, in animals, for heart effects.
IGF-1 LR3
A long-acting laboratory analogue of insulin-like growth factor 1, sold for muscle growth with almost no human data behind it.
Ipamorelin
A selective growth hormone secretagogue studied for its relatively clean release of growth hormone with less effect on appetite and stress hormones than earlier peptides.
MGF (mechano growth factor)
A muscle-derived IGF-1 variant sold for local repair; every claim rests on animal and cell work.
Sermorelin
A GHRH fragment that briefly triggers growth-hormone release; it once had a licensed diagnostic use and now circulates only as a research or compounded product.
Tesamorelin
A stabilised growth-hormone-releasing hormone analogue approved for excess visceral fat in HIV-associated lipodystrophy — and for nothing else.